RxDoctor Payments DataLook up a doctor →

Lori Eaton, NP

Adult Health · Matthews, NCNPI 1184916892

Payments from drug & device makers

$11,025in general payments, 2019–2025

Across 532 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Pfizer$983
  • AstraZeneca$718
  • Boehringer Ingelheim$525
  • Lilly USA, LLC$444
  • plus $5K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie94$1,926
Novo Nordisk77$1,541
Pfizer49$983
AstraZeneca35$718
Boehringer Ingelheim25$525
Lilly USA, LLC23$444
Astellas Pharma US Inc18$406
Johnson & Johnson11$316
GSK9$281
Amgen(2 entities)13$252
Bayer13$234
Takeda Pharmaceuticals U.S.A., Inc.14$227
Esperion Therapeutics, Inc.7$225
Axsome Therapeutics, Inc.5$196
Novartis13$192
Biohaven Pharmaceutical Holding Company Ltd.10$185
Teva Pharmaceuticals USA, Inc.5$170
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$165
Sumitomo Pharma America, Inc.8$161
Paratek Pharmaceuticals, Inc.3$153
Xeris Pharmaceuticals, Inc.9$153
Dexcom, Inc.2$129
Abbott5$103
Biohaven Pharmaceuticals, Inc.5$97
Bausch Health US, LLC6$91
IBSA Pharma Inc.5$75
Amarin Pharma, Inc.4$74
Shield Therapeutics Inc4$71
Idorsia Pharmaceuticals US Inc4$64
Insightec,inc1$63
Eisai Inc.4$60
Daiichi Sankyo Inc.3$60
Kowa Pharmaceuticals America, Inc.3$52
Corcept Therapeutics3$51
Merck3$48
Azurity Pharmaceuticals, Inc.2$40
Neos Therapeutics, LP2$40
Sanofi-aventis U.S. LLC2$40
Sunovion Pharmaceuticals Inc.2$35
Inspire Medical Systems, Inc.2$35
Tolmar, Inc.2$33
E.r. Squibb & Sons, L.L.C.2$28
Medtronic2$27
Ironwood Pharmaceuticals, Inc1$24
Hikma Pharmaceuticals USA1$22
Actelion Pharmaceuticals US, Inc.1$20
Renalytix AI, Inc.1$19
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$19
Upsher-smith Laboratories LLC1$18
Edwards Lifesciences1$18
Supernus Pharmaceuticals, Inc.1$18
Phadia US Inc.1$17
Arbor Pharmaceuticals, Inc.1$17
Phathom Pharmaceuticals, Inc.1$17
GRT US Holding, Inc.1$17
Amneal Pharmaceuticals LLC1$16
Organon1$16

How this compares

$11,025 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$26,371
Medicare patients
129
Services billed
463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Matthews

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →